epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Annovera
    segesterone acetate/ ethinyl estradiol vaginal
  • remove Migranal
    dihydroergotamine nasal

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Annovera (segesterone acetate/ ethinyl estradiol vaginal) + Migranal (dihydroergotamine nasal)

Monitor/Modify Tx


ethinyl estradiol (contraceptive) + dihydroergotamine

monitor BP: combo may incr. dihydroergotamine levels, risk of ergot toxicity, severe vasospasm, ischemia, HTN, other adverse effects (hepatic metabolism inhibited, additive effects)

Additional Considerations

Smiley face Smiley face segesterone (contraceptive) in Annovera

avoid concurrent use of oil/silicone-based vaginal products, may consider water-based vaginal products; combo may incr. ethinyl estradiol and segesterone exposure, risk of adverse effects; may alter vaginal ring performance, decr. long-term efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information